Evidence map›Paper›PMID 30101009›Full record

ReviewMolecular and clinical oncology2018

Impact of multidisciplinary tumor boards on patients with rectal cancer.

Argyrios Ioannidis, Michael Konstantinidis, Sotirios Apostolakis, Christos Koutserimpas, Nikolaos Machairas, Konstantinos M Konstantinidis

Open access · diamondAbstract readReview
In one paragraph

Review in Molecular and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. An IT Platform Supporting Rectal Cancer Tumor Board Activities: Implementation Process and Impact Analysis.International journal of environmental research and public health · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Argyrios IoannidisDepartment of General, Laparoscopic, Robotic and Bariatric Surgery, Athens Medical Center, 15125 Athens, Greece.
Michael KonstantinidisNational and Kapodistrian University of Athens, School of Medicine, 11527 Athens, Greece.
Sotirios ApostolakisDepartment of Neurosurgery, KAT General Hospital of Attica, 14561 Athens, Greece.
Christos KoutserimpasDepartment of Orthopaedics and Traumatology, '251' Hellenic Air Force General Hospital, 11525 Athens, Greece.
Nikolaos Machairas3rd Department of Surgery, University Hospital Attikon, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Konstantinos M KonstantinidisDepartment of General, Laparoscopic, Robotic and Bariatric Surgery, Athens Medical Center, 15125 Athens, Greece.
Athens Medical Center · GRNational and Kapodistrian University of Athens · GRGeneral Hospital of Attica · GRHellenic Air Force · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Οncological outcomes in patients with primary rectal cancer have markedly improved over the last few years, mainly due to the widespread application of the total mesorectal excision technique. This improvement should also be largely attributed to multiple specialties, other than colorectal surgery, such as radiology, oncology and pathology. Therefore, a multimodal approach is key to efficient and appropriate rectal cancer management. Multidisciplinary tumor (MDT) boards have become an important asset for the management and treatment of patients with rectal cancer, and a number of studies published to date suggest the beneficial effect of the multidisciplinary approach on the management of such patients. The available evidence demonstrates a modification of the treatment plan, attributed to the MDT implementation, in a non-negligible proportion of these patients. However, more studies are required in order to assess the exact impact of MDT boards on disease-free and overall survival of patients with primary rectal cancer.

Indexed as

multidisciplinary tumor boardmultidisciplinary tumor conferencemultidisciplinary tumor meetingrectal cancer

Identifiers

PMID30101009
PMCPMC6083403
OpenAlexW2808355567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.